164 related articles for article (PubMed ID: 31235410)
21. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization.
Cerban R; Ester C; Iacob S; Grasu M; Pâslaru L; Dumitru R; Lupescu I; Constantin G; Croitoru A; Gheorghe L
J Gastrointestin Liver Dis; 2018 Dec; 27(4):409-417. PubMed ID: 30574623
[TBL] [Abstract][Full Text] [Related]
22. Role of C-arm CT in identifying caudate arteries supplying hepatocellular carcinoma.
Choi WS; Kim HC; Hur S; Choi JW; Lee JH; Yu SJ; Chung JW
J Vasc Interv Radiol; 2014 Sep; 25(9):1380-8. PubMed ID: 24713418
[TBL] [Abstract][Full Text] [Related]
23. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma.
Lucatelli P; Argirò R; Ginanni Corradini S; Saba L; Cirelli C; Fanelli F; Ricci C; Levi Sandri GB; Catalano C; Bezzi M
J Vasc Interv Radiol; 2017 Jul; 28(7):978-986. PubMed ID: 28495451
[TBL] [Abstract][Full Text] [Related]
25. Cone-Beam Computed Tomography (CBCT) Hepatic Arteriography in Chemoembolization for Hepatocellular Carcinoma: Performance Depicting Tumors and Tumor Feeders.
Lee IJ; Chung JW; Yin YH; Kim HC; Kim YI; Jae HJ; Park JH
Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1218-30. PubMed ID: 25720741
[TBL] [Abstract][Full Text] [Related]
26. Hepatic Arterial Embolization Using Cone Beam CT with Tumor Feeding Vessel Detection Software: Impact on Hepatocellular Carcinoma Response.
Cornelis FH; Borgheresi A; Petre EN; Santos E; Solomon SB; Brown K
Cardiovasc Intervent Radiol; 2018 Jan; 41(1):104-111. PubMed ID: 28770316
[TBL] [Abstract][Full Text] [Related]
27. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
[TBL] [Abstract][Full Text] [Related]
28. Chemoembolization for hepatocellular carcinoma supplied by a lumbar artery.
Kim HM; Kim HC; Woo S; Son KR; Cho SW; Chung JW
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):121-8. PubMed ID: 24849301
[TBL] [Abstract][Full Text] [Related]
29. Role of C-arm cone-beam CT in chemoembolization for hepatocellular carcinoma.
Kim HC
Korean J Radiol; 2015; 16(1):114-24. PubMed ID: 25598679
[TBL] [Abstract][Full Text] [Related]
30. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.
Kim EH; Oh JS; Chun HJ; Choi BG; Lee HG
Diagn Interv Radiol; 2018 Sep; 24(5):262-267. PubMed ID: 30211679
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy.
Paul SB; Sahu P; Sreenivas V; Nadda N; Gamanagatti SR; Nayak B; Shalimar S; Acharya SK
Scand J Gastroenterol; 2019 Sep; 54(9):1132-1137. PubMed ID: 31483691
[No Abstract] [Full Text] [Related]
33. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
Iwazawa J; Ohue S; Hashimoto N; Muramoto O; Mitani T
Eur J Radiol; 2012 Dec; 81(12):3985-92. PubMed ID: 22959287
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
[TBL] [Abstract][Full Text] [Related]
35. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Jeong Y; Yoon SM; Han S; Shim JH; Kim KM; Lim YS; Lee HC; Kim SY; Park JH; Lee SW; Ahn SD; Choi EK; Kim JH
PLoS One; 2015; 10(8):e0135298. PubMed ID: 26252472
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Accuracy of Split-Bolus Single-Phase Contrast-Enhanced Cone-Beam CT for the Detection of Liver Tumors before Transarterial Chemoembolization.
Jonczyk M; Chapiro J; Collettini F; Geisel D; Schnapauff D; Streitparth F; Schmidt T; Hamm B; Gebauer B; Wieners G
J Vasc Interv Radiol; 2017 Oct; 28(10):1378-1385. PubMed ID: 28747271
[TBL] [Abstract][Full Text] [Related]
37. The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma.
Müller K; Datta S; Gehrisch S; Ahmad M; Mohammed MA; Rosenberg J; Hwang GL; Louie JD; Sze DY; Kothary N
J Vasc Interv Radiol; 2017 Feb; 28(2):238-245. PubMed ID: 27914917
[TBL] [Abstract][Full Text] [Related]
38. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
39. Transcatheter arterial chemoembolization for hepatocellular carcinoma: prospective assessment of the right inferior phrenic artery with C-arm CT.
Kim HC; Chung JW; Park JH; An S; Son KR; Seong NJ; Jae HJ
J Vasc Interv Radiol; 2009 Jul; 20(7):888-95. PubMed ID: 19481471
[TBL] [Abstract][Full Text] [Related]
40. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
